The correlation between serum high sensitivity C-reactive protein and leptin in reproductive age overweight/obese women in Erbil city

Showan D. Hussain

doi:10.15218/zjms.2012.0030

Authors

Showan D. Hussain Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2012.0030

Keywords:

High sensitivity C reactive protein, Leptin, Obesity, Body Mass Index

Abstract

Background and objectives: Leptin could be a key regulator of C-reactive protein (CRP) levels, which serve as a marker of systemic inflammation. Both leptin and CRP are predictors of cardiovascular disease (CVD). This study, attempted to characterize the association between inflammatory marker hs-CRP and serum leptin in overweight/obese women in reproductive age in comparison with normal body mass index women (BMI) as a control group. Methods: Eighty reproductive age women were divided into two groups: first group of 50 overweight / obese women; with mean age 27.7 years and BMI mean (31.4 Kg/m²). The second group of 30 age-matched women with mean age 28.8 years and BMI mean (22.5 Kg/m²) which served as control group. Any subject with other diseases or on medication that might affect the study was excluded. Fasting blood samples for both groups were collected and serum hs-CRP, leptin, lipid profile and glucose were measured Results: In the overweight / obese group hs-CRP concentrations were significantly associated with BMI and leptin (r =0.3, r =0.284, with p <0.05) respectively. This association remained significant, even after adjusting BMI, for each one unit increase in serum leptin the serum hs-CRP escalated by a mean of 0.05 (mg/L). Serum Leptin notably has a more significant role than BMI in explaining changes of serum hs-CRP since its standardized coefficient was higher (ß =0.384 with p=0.001) versus (ß =0.266 with p=0.016) for BMI in overweight and obese women. Conclusion: Leptin is a stronger predictor of hs-CRP than BMI in overweight and obese women in reproductive age.

Metrics

Metrics Loading ...

References

Halaas JL, Gajiwala KS, Maffei M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543–6.

Considine RV, Sinha MK, Heiman ML. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–5.

Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409–14.

Haynes WG, Morgan DA, Walsh SA. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest.1997; 100:270–8.

Konstantinides S, Schafer K, Koschnick S. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest 2001; 108: 1533–40.

Corsonello A, Malara A, Ientile R. Leptin enhances adenosine diphosphate-induced platelet aggregation in healthy subjects. Obes Res.2002; 10: 306.

Sader S, Nian M, Liu P. Leptin: a novel link between obesity, diabetes, cardiovascular risk, and ventricular hypertrophy. Circulation 2003; 108: 644–6.

Leyva F, Godsland IF, Ghatei M. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928–33.

Soderberg S, Ahren B, Jansson JH. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409–18.

10.Wallace AM, McMahon AD, Packard CJ. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104:3052-6.

Castell J, Gomez-Lechion M, David M. Acute phase response of human hepatocyte: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179–86.

Baumann H, Morella KK, White DW. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A.1996; 93: 8374-8.

Gualillo O, Eiras S, Lago F. Elevated serum leptin concentrations induced by experimental acute inflammation. Life Sci.2000; 67: 2433–41.

Van Dielen FM, Van’t Veer C, Schols AM. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord.2001; 25: 1759–66.

Sarraf P, Frederich RC, Turner EM. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185: 171–5.

Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obestet Gynecol 2002;186: 969-77.

Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H , Hainque B. .Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. Journal of Clinical Endocrinology and Metabolism 2000; 85: 3338–42.

Bullo M, Garcia-Lorda P, Megias I & Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research 2003 ;11: 525–31.

Shamsuzzaman AS,Winnicki M,Wolk R, Svatikova A, Phillips BG, Davison DE, Berger PB & Somers VK. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004 ;109 :2181–85.

Meyers JA, Liu AY, McTiernan A , “Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women . Journal of Endocrinology 2008; 199 no.(1) : 51–60.

Santos-Alvarez,J R. Goberna V, Sanchez-Margalet S,“Human leptin stimulates proliferation and activation of human circulating monocytes. Cellular Immunology 1999; 194 no.( 1): 6–11

Corral AR, Johnson JS, Jimenez FL, Thomas RJ. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Cardiovascular Medicine 2008; 1:1-8.

Wolk R .Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44: 1819–24.